Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction
Open Access
- 1 April 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 13 (4) , 695-705
- https://doi.org/10.1359/jbmr.1998.13.4.695
Abstract
Low bone mineral density (BMD) is a major risk factor for development of osteoporosis; increasing evidence suggests that attainment and maintenance of peak bone mass as well as bone turnover and bone loss have strong genetic determinants. We examined the association of BMD levels and their change over a 3-year period, and polymorphisms of the estrogen receptor (ER), vitamin D receptor (VDR), type I collagen, osteonectin, osteopontin, and osteocalcin genes in pre- and perimenopausal women who were part of the Michigan Bone Health Study, a population-based longitudinal study of BMD. Body composition measurements, reproductive hormone profiles, bone-related serum protein measurements, and life-style characteristics were also available on each woman. Based on evaluation of women, ER genotypes (identified by PvuII [n = 253] and XbaI [n = 248]) were significantly predictive of both lumbar spine (p < 0.05) and total body BMD level, but not their change over the 3-year period examined. The VDR BsmI restriction fragment length polymorphism was not associated with baseline BMD, change in BMD over time, or any of the bone-related serum and body composition measurements in the 372 women in whom it was evaluated. Likewise, none of the other polymorphic markers was associated with BMD measurements. However, we identified a significant gene × gene interaction effect (p < 0.05) for the VDR locus and PvuII (p < 0.005) and XbaI (p < 0.05) polymorphisms, which impacted BMD levels. Women who had the (−/−) PvuII ER and bb VDR genotype combination had a very high average BMD, while individuals with the (−/−) PvuII ER and BB VDR genotype had significantly lower BMD levels. This contrast was not explained by differences in serum levels of osteocalcin, parathyroid hormone, 1,25-dihydroxyvitamin D, or 25-dihydroxyvitamin D. These data suggest that genetic variation at the ER locus, singly and in relation to the vitamin D receptor gene, influences attainment and maintenance of peak bone mass in younger women, which in turn may render some individuals more susceptible to osteoporosis than others.Keywords
This publication has 51 references indexed in Scilit:
- A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral densityJournal of Bone and Mineral Research, 1996
- The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: A study of postmenopausal twinsJournal of Bone and Mineral Research, 1996
- Bone fragility in transgenic mice expressing a mutated gene for type I procollagen (COL1A1) parallels the age-dependent phenotype of human osteogenesis imperfectaJournal of Bone and Mineral Research, 1995
- Association of Estrogen Receptor Dinucleotide Repeat Polymorphism with OsteoporosisBiochemical and Biophysical Research Communications, 1995
- Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal womenJournal of Bone and Mineral Research, 1995
- Genomic Organization of the Human Osteopontin Gene: Exclusion of the Locus from a Causative Role in the Pathogenesis of Dentinogenesis Imperfecta Type IIGenomics, 1995
- Mutation analysis of coding sequences for type I procollagen in individuals with low bone densityJournal of Bone and Mineral Research, 1994
- Apal, Bsml, EcoRV and Taql polymorphisms at the human vitamin D receptor gene locus in Caucasians, Blacks and AsiansHuman Molecular Genetics, 1993
- An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.Journal of Clinical Investigation, 1992
- Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3Biochemistry, 1988